BeneFIX Biosimilar, Recombinant Coagulation Factor IX C019P Syd Labs | Ushelf
BeneFIX Biosimilar, Recombinant Coagulation Factor IX C019P Syd Labs | Ushelf

BeneFIX Biosimilar, Recombinant Coagulation Factor IX | C019P

Alemtuzumab Biosimilar, Human IgG1 L234A L235A P329G (LALAPG) C040P.LA Syd Labs | Ushelf Alemtuzumab Biosimilar, Human IgG1 L234A L235A P329G (LALAPG) | C040P.LA
Clotting Factor VIII Biosimilar C018 Syd Labs | Ushelf Clotting Factor VIII Biosimilar | C018
BeneFIX Biosimilar, Recombinant Coagulation Factor IX C019P Syd Labs | Ushelf

BeneFIX Biosimilar, Recombinant Coagulation Factor IX | C019P

In stock
Catalog No.: C019P | In Vivo Grade

BeneFIX biosimilar CHO stable cell line is available for licensing to manufacture the recombinant coagulation factor IX protein.

The research grade BeneFIX biosimilar protein is for research use only.

This product is currently out of stock and unavailable.

Catalog No. C019P
Product Name BeneFIX Biosimilar, Recombinant Coagulation Factor IX
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Source/Host The BeneFIX biosimilar protein was produced in the BeneFIX biosimilar CHO stable cell line.
Specificity/Sensitivity The BeneFIX biosimilar protein specifically
Applications Functional assays
Form Of Antibody 0.2 uM filtered solution, no stabilizers or preservatives
Endotoxin < 0.1 EU per 1 ug of the protein by the LAL method
Purity >95% by SDS-PAGE under reducing conditions and HPLC
Shipping The BeneFIX biosimilar protein is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied
Note BeneFIX biosimilar CHO stable cell line is available for licensing to manufacture the recombinant coagulation factor IX protein. The research grade BeneFIX biosimilar protein is for research use only.
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card.

Description

C019P: BeneFIX Biosimilar, Recombinant Coagulation Factor IX

Recombinant Coagulation Factor IX protein.

BeneFIX, recombinant coagulation factor IX, is used to treat hemophilia B. Lack of Factor IX (Christmas factor), one of the serine proteases of the coagulation system, causes hemophilia B, a recessive X-linked genetic disorder and about 20% of haemophilia cases.

Syd Labs also provides the following clotting or coagulation-related biosimilar proteins:
Advate / Kogenate Biosimilar, Recombinant Factor VIII
ReFacto Biosimilar, Recombinant truncated Factor VIII
NovoSeven Biosimilar, Recombinant Factor VIIa

You may also like…